Erythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men

[1]  G. Egeland,et al.  Plasma fatty acids and desaturase activity are associated with circulating adiponectin in healthy adolescent girls. , 2010, The Journal of clinical endocrinology and metabolism.

[2]  A. Kristal,et al.  Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. , 2010, The American journal of clinical nutrition.

[3]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[4]  W. Harris,et al.  Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. , 2009, Atherosclerosis.

[5]  E. Ding,et al.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. , 2009, JAMA.

[6]  E. Schmidt,et al.  Adiponectin and marine n-3 fatty acids in patients referred for coronary angiography. , 2009, International journal of cardiology.

[7]  P. Calder.  Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. , 2009, Biochimie.

[8]  M. Sandhu,et al.  Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis , 2009, Diabetologia.

[9]  L. Lind,et al.  Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. , 2009, Atherosclerosis.

[10]  Y. E. Chen,et al.  PPARgamma and its ligands: therapeutic implications in cardiovascular disease. , 2009, Clinical science.

[11]  E. Manzato,et al.  Plasma lipids and inflammation in active inflammatory bowel diseases , 2009, Alimentary pharmacology & therapeutics.

[12]  F. Visseren,et al.  Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. , 2008, European heart journal.

[13]  S. Virtanen,et al.  The Pro12Ala polymorphism of the PPAR-γ2 gene affects associations of fish intake and marine n−3 fatty acids with glucose metabolism , 2008, European Journal of Clinical Nutrition.

[14]  Thomas Illig,et al.  FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. , 2008, The American journal of clinical nutrition.

[15]  J. Danesh,et al.  C‐reactive protein and coronary heart disease: a critical review , 2008, Journal of internal medicine.

[16]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[17]  L. Weinehall,et al.  Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[18]  D. Mozaffarian,et al.  Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. , 2008, The American journal of clinical nutrition.

[19]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[20]  S. Basu,et al.  Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation : longitudinal analyses in middle-aged men , 2008, British Journal of Nutrition.

[21]  L. Lauritzen,et al.  Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. , 2008, The Journal of nutrition.

[22]  P. Havel,et al.  Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. , 2008, Metabolic syndrome and related disorders.

[23]  H. Takeuchi,et al.  Alpha-linolenic acid-rich flaxseed oil ingestion increases plasma adiponectin level in rats. , 2008, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[24]  D. Laaksonen,et al.  Dietary fatty acids and cardiovascular disease: an epidemiological approach. , 2008, Progress in lipid research.

[25]  P. Kraft,et al.  Ala12 variant of the peroxisome proliferator-activated receptor-gamma gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction. , 2007, The American journal of clinical nutrition.

[26]  D. Altshuler,et al.  The Pro12Ala variant at the peroxisome proliferator-activated receptor γ gene and change in obesity-related traits in the Diabetes Prevention Program , 2007, Diabetologia.

[27]  T. Nelson,et al.  Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults. , 2007, Metabolism: clinical and experimental.

[28]  D. Panagiotakos,et al.  Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men , 2007, European journal of nutrition.

[29]  D. English,et al.  Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.

[30]  U. Das.  A defect in the activity of Δ6 and Δ5 desaturases may be a factor in the initiation and progression of atherosclerosis , 2007 .

[31]  K. Walsh,et al.  Adiponectin actions in the cardiovascular system. , 2007, Cardiovascular research.

[32]  R. Rodrigo,et al.  Polyunsaturated Fatty Acid Pattern in Liver and Erythrocyte Phospholipids from Obese Patients , 2007, Obesity.

[33]  Jifeng Zhang,et al.  Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators* , 2006, Journal of Biological Chemistry.

[34]  J. Danesh,et al.  Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.

[35]  L. Arterburn,et al.  Distribution, interconversion, and dose response of n-3 fatty acids in humans. , 2006, The American journal of clinical nutrition.

[36]  P. Calder,et al.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[37]  S. Bandinelli,et al.  Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. , 2006, The Journal of clinical endocrinology and metabolism.

[38]  B. Vessby,et al.  Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men , 2005, Diabetologia.

[39]  J. Fernández-Real,et al.  Circulating adiponectin and plasma fatty acid profile. , 2005, Clinical chemistry.

[40]  Jifeng Zhang,et al.  Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand , 2005 .

[41]  Manabu T. Nakamura,et al.  STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES , 2004 .

[42]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[43]  J. Pankow,et al.  Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, The American journal of clinical nutrition.

[44]  M. Laakso,et al.  Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. , 2003, Molecular genetics and metabolism.

[45]  E. Rimm,et al.  Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. , 2003, Clinical chemistry.

[46]  M. Stumvoll,et al.  The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism , 2002 .

[47]  Manabu T. Nakamura,et al.  Metabolism and functions of highly unsaturated fatty acids: An update , 2001, Lipids.

[48]  S. O’Rahilly,et al.  Evidence for Gene-Nutrient Interaction at the PPARγ Locus , 2001 .

[49]  J. Lehmann,et al.  Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. , 2000, Molecular cell.

[50]  H. Boeing,et al.  EPIC-Germany – A Source for Studies into Diet and Risk of Chronic Diseases , 1999, Annals of Nutrition and Metabolism.

[51]  A. J. Hulbert,et al.  Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity. , 1998, Current opinion in clinical nutrition and metabolic care.

[52]  A. Folsom,et al.  Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1995, The American journal of clinical nutrition.

[53]  A. J. Hulbert,et al.  Dietary fats, membrane phospholipids and obesity. , 1994, The Journal of nutrition.

[54]  M. Schulze,et al.  Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2011, The American journal of clinical nutrition.

[55]  Walter C Willett,et al.  Dietary fats and prevention of type 2 diabetes. , 2009, Progress in lipid research.

[56]  K. Duffin,et al.  Novel, selective Δ6 or Δ5 fatty acid desaturase inhibitors as antiinflammatory agents in mice , 2007, Lipids.